Article info

Download PDFPDF
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer

Authors

  1. Address for correspondence: M.C. Palmer, Department of Medicine, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2.

Citation

PALMER MC, SHEPERT E, SCHEPANSKY A, et al
Novel, dose intensive, single-agent cisplatin in the first-line management of advanced stage ovarian cancer

Publication history

  • First published November 1, 1992.
Online issue publication 
November 01, 1992

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.